The article titled “Angiogenesis in Pituitary Adenomas: Human Studies and New Mutant Mouse Models” [1] reused wording from a book chapter published the same year by the same author group, “Prolactinomas: Role of VEGF, FGF-2 and CD31” in Tumors of the Central Nervous System [2], which was not cited. The review brought together the results of the authors’ previous experimental work on angiogenesis and pituitary adenomas in the context of the literature.
Corrigendum | Open Access
Corrigendum to “Angiogenesis in Pituitary Adenomas: Human Studies and New Mutant Mouse Models”
Received30 Jun 2020
Accepted30 Jun 2020
Published18 Jul 2020
References
C. Cristina, G. María Luque, G. Demarchi et al., “Angiogenesis in pituitary adenomas: human studies and new mutant mouse models,” International Journal of Endocrinology, vol. 2014, Article ID 608497, 11 pages, 2014.
View at: Publisher Site | Google ScholarM. Ines, M. Perez, C. Cristina, S. Inés Berner, and D. Becu-Villalobos, “Prolactinomas: role of VEGF, FGF-2 and CD31,” in Tumors of the Central Nervous System, M. A. Hayat, Ed., vol. 12, pp. 33–41, Springer Science+Business Media, Dordrecht, Netherlands, 2014.
View at: Publisher Site | Google Scholar
Copyright
Copyright © 2020 Carolina Cristina et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.